Olivier Bézy

ORCID: 0000-0003-4367-5043
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adipose Tissue and Metabolism
  • Birth, Development, and Health
  • Health, Medicine and Society
  • Adipokines, Inflammation, and Metabolic Diseases
  • Psychoanalysis and Psychopathology Research
  • GDF15 and Related Biomarkers
  • Nutrition and Health in Aging
  • Social Policies and Family
  • Nutrition, Genetics, and Disease
  • Nuclear Structure and Function
  • Palliative Care and End-of-Life Issues
  • Aging, Elder Care, and Social Issues
  • Healthcare Systems and Practices
  • Macrophage Migration Inhibitory Factor
  • Metabolism, Diabetes, and Cancer
  • Diet and metabolism studies
  • Family Support in Illness
  • Pancreatic function and diabetes
  • Endoplasmic Reticulum Stress and Disease
  • Childhood Cancer Survivors' Quality of Life
  • Lipoproteins and Cardiovascular Health
  • Cancer-related cognitive impairment studies
  • Mitochondrial Function and Pathology
  • Stress Responses and Cortisol
  • Hormonal Regulation and Hypertension

Pfizer (United States)
2012-2024

University of Pennsylvania
2023

Joslin Diabetes Center
2007-2018

Centre Jean Perrin
2006-2016

Harvard University
2007-2015

Centre Hospitalier Universitaire de Clermont-Ferrand
2000-2013

Hôpital Saint-Jacques
2013

Brigham and Women's Hospital
2010

Centre National de la Recherche Scientifique
2003-2005

Centre Antoine Lacassagne
2003

Obesity, diabetes, and metabolic syndrome result from complex interactions between genetic environmental factors, including the gut microbiota. To dissect these interactions, we utilized three commonly used inbred strains of mice—obesity/diabetes-prone C57Bl/6J mice, obesity/diabetes-resistant 129S1/SvImJ Jackson Laboratory, obesity-prone but diabetes-resistant 129S6/SvEvTac Taconic—plus derivative lines generated by breeding in a new, common environment. Analysis parameters microbiota all...

10.1016/j.cmet.2015.07.007 article EN publisher-specific-oa Cell Metabolism 2015-08-20

Mitochondrial dysfunction in adipose tissue occurs obesity, type 2 diabetes, and some forms of lipodystrophy, but whether this contributes to or is the result these disorders unknown. To investigate physiological consequences severe mitochondrial impairment tissue, we generated mice deficient transcription factor A (TFAM) adipocytes by using carrying adiponectin-Cre TFAM floxed alleles. These adiponectin TFAM-knockout (adipo-TFAM-KO) had a 75–81% reduction subcutaneous intra-abdominal white...

10.1096/fj.14-253971 article EN The FASEB Journal 2014-07-08

C57BL/6J and 129S6/Sv (B6 129) mice differ dramatically in their susceptibility to developing diabetes response diet- or genetically induced insulin resistance. A major locus contributing this difference has been mapped a region on mouse chromosome 14 that contains the gene encoding PKCδ. Here, we found PKCδ expression liver was 2-fold higher B6 versus 129 from birth further increased but not high-fat diet. PRKCD also elevated obese humans positively correlated with fasting glucose...

10.1172/jci46045 article EN Journal of Clinical Investigation 2011-05-16

Exposure of preadipocytes to long-chain fatty acids induces the expression several markers adipocyte differentiation. In an attempt identify novel genes and proteins that are regulated by in preadipocytes, we performed a substractive hybridization screening identified PTX3, protein pentraxin family. PTX3 mRNA is transient during differentiation clonal cell lines absent fully differentiated cells. Stable overexpression has no effect on line with this, expressed stromal-vascular fraction...

10.1194/jlr.m200382-jlr200 article EN cc-by Journal of Lipid Research 2003-05-01

Obesity, especially visceral obesity, is associated with insulin resistance and metabolic syndrome. We previously identified the cell surface proteoglycan glypican-4 as differentially expressed in subcutaneous versus white fat depots. Here we show that released from cells adipose tissue explants of mice, circulating levels correlate BMI sensitivity humans. Furthermore, interacts receptor, enhances receptor signaling, adipocyte differentiation. Conversely, depletion results reduced activation...

10.2337/db11-1395 article EN cc-by-nc-nd Diabetes 2012-06-30

Increased intraabdominal (visceral) fat is associated with a high risk of diabetes and metabolic syndrome. We have previously shown that the mesodermal developmental transcription factor Tbx15 highly differentially expressed between visceral subcutaneous (s.c.) in both humans rodents, expression decreased obesity. Here we show that, mice, 260-fold more s.c. preadipocytes than epididymal preadipocytes. Overexpression 3T3-L1 impairs adipocyte differentiation decreases triglyceride content....

10.1073/pnas.1019704108 article EN Proceedings of the National Academy of Sciences 2011-01-31

TRB3 has been implicated in the regulation of several biological processes mammalian cells through its ability to influence Akt and other signaling pathways. In this study, we investigated role regulating adipogenesis activity adipogenic transcription factors. We find that is expressed 3T3-L1 preadipocytes, expression transiently suppressed during initial days differentiation concomitant with induction C/EBPbeta. This event appears be a prerequisite for adipogenesis. Overexpression blocks at...

10.1128/mcb.00375-07 article EN Molecular and Cellular Biology 2007-07-24

OBJECTIVE Type 2 diabetes and obesity are increasingly affecting human populations around the world. Our goal was to identify early molecular signatures predicting genetic risk these metabolic diseases using two strains of mice that differ greatly in disease susceptibility. RESEARCH DESIGN AND METHODS We integrated characterization, gene expression, protein-protein interaction networks, RT-PCR, flow cytometry analyses adipose, skeletal muscle, liver tissue diabetes-prone C57BL/6NTac (B6)...

10.2337/db10-0367 article EN cc-by-nc-nd Diabetes 2010-08-16

Protein kinase C (PKC)δ has been shown to be increased in liver obesity and plays an important role the development of hepatic insulin resistance both mice humans. In current study, we explored PKCδ skeletal muscle control sensitivity glucose metabolism by generating which was deleted specifically using Cre-lox recombination. Deletion improved signaling young mice, especially at low doses; however, this did not change tolerance or tests done with pharmacological levels insulin. Likewise,...

10.2337/db14-1891 article EN Diabetes 2015-08-25

Growth differentiation factor 15 (GDF15) causes anorexia and weight loss in animal models, higher circulating levels are associated with cachexia reduced survival cancer other chronic diseases such as sepsis. To investigate the role of sepsis-induced GDF15, we examined whether GDF15 neutralization via a validated highly potent monoclonal antibody, mAB2, modulates lipopolysaccharide (LPS)-induced anorexia, loss, mortality rodents. LPS injection transiently increased wild-type mice, decreased...

10.1016/j.isci.2021.102554 article EN cc-by-nc-nd iScience 2021-05-19

Abstract GDF15 is a distant TGF-β family member that induces anorexia and weight loss. Due to its function, has attracted attention as potential therapeutic for the treatment of obesity associated metabolic diseases. However, pharmacokinetic physicochemical properties present several challenges development therapeutic, including short half-life, high aggregation propensity, protease susceptibility in serum. Here, we report design, characterization optimization an Fc-fusion protein format...

10.1038/s41598-021-87959-5 article EN cc-by Scientific Reports 2021-04-26

Growth differentiation factor 15 (GDF15), a TGFβ superfamily cytokine, acts through its receptor, cell line-derived neurotrophic factorfamily receptor α-like (GFRAL), to suppress food intake and promote nausea. GDF15 is broadly expressed at low levels but increases in states of disease such as cancer, cachexia, sepsis. Whether necessary for inducing sepsis-associated anorexia body weight loss currently unclear. To test this we used model moderate systemic infection GDF15KO GFRALKO mice with...

10.1152/ajpgi.00146.2021 article EN AJP Gastrointestinal and Liver Physiology 2021-12-22

Abstract Urocortin 2 (UCN2) acts as a ligand for the G protein-coupled receptor corticotropin-releasing hormone (CRHR2). UCN2 has been reported to improve or worsen insulin sensitivity and glucose tolerance in vivo. Here we show that acute dosing of induces systemic resistance male mice skeletal muscle. Inversely, chronic elevation by injection with adenovirus encoding resolves metabolic complications, improving tolerance. CRHR2 recruits Gs response low concentrations UCN2, well Gi...

10.1038/s41467-023-39597-w article EN cc-by Nature Communications 2023-07-04
Coming Soon ...